Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.
2.

Breast pathology: rationale for adopting the ductal intraepithelial neoplasia (DIN) classification.

Tavassoli FA.

Nat Clin Pract Oncol. 2005 Mar;2(3):116-7. No abstract available.

PMID:
16264885
3.

Premalignant and in situ breast disease: biology and clinical implications.

Arpino G, Laucirica R, Elledge RM.

Ann Intern Med. 2005 Sep 20;143(6):446-57.

PMID:
16172443
5.

The management of ductal carcinoma in situ in North America and Europe. Results of a survey.

Ceilley E, Jagsi R, Goldberg S, Kachnic L, Powell S, Taghian A.

Cancer. 2004 Nov 1;101(9):1958-67.

6.

Ductal carcinoma in situ of the breast.

Burstein HJ, Polyak K, Wong JS, Lester SC, Kaelin CM.

N Engl J Med. 2004 Apr 1;350(14):1430-41. Review. No abstract available.

PMID:
15070793
7.

A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer.

Rakovitch E, Franssen E, Kim J, Ackerman I, Pignol JP, Paszat L, Pritchard KI, Ho C, Redelmeier DA.

Breast Cancer Res Treat. 2003 Feb;77(3):285-93.

PMID:
12602928
8.

"Well, have I got cancer or haven't I?" The psycho-social issues for women diagnosed with ductal carcinoma in situ.

De Morgan S, Redman S, White KJ, Cakir B, Boyages J.

Health Expect. 2002 Dec;5(4):310-8.

PMID:
12460220
9.

Detection of ductal carcinoma in situ in women undergoing screening mammography.

Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, Yankaskas BC, Rosenberg R, Carney PA, Kerlikowske K, Taplin SH, Urban N, Geller BM.

J Natl Cancer Inst. 2002 Oct 16;94(20):1546-54.

10.
11.

Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma.

Ernster VL, Barclay J.

J Natl Cancer Inst Monogr. 1997;(22):151-6. Review.

PMID:
9709292
12.

Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci.

O'Connell P, Pekkel V, Fuqua SA, Osborne CK, Clark GM, Allred DC.

J Natl Cancer Inst. 1998 May 6;90(9):697-703.

13.
14.

Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast.

Chuaqui RF, Zhuang Z, Emmert-Buck MR, Liotta LA, Merino MJ.

Am J Pathol. 1997 Jan;150(1):297-303.

15.
16.

Prognostic significance of benign proliferative breast disease.

Bodian CA, Perzin KH, Lattes R, Hoffmann P, Abernathy TG.

Cancer. 1993 Jun 15;71(12):3896-907.

17.

Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization.

Bellamy CO, McDonald C, Salter DM, Chetty U, Anderson TJ.

Hum Pathol. 1993 Jan;24(1):16-23.

PMID:
8380275
18.

1991 national survey of carcinoma of the breast by the Commission on Cancer.

Osteen RT, Cady B, Chmiel JS, Clive RE, Doggett RL, Friedman MA, Hussey DH, Kraybill WG, Urist MM, Winchester DP.

J Am Coll Surg. 1994 Mar;178(3):213-9.

PMID:
8149010
19.

Immunohistochemical studies of early breast cancer evolution.

Allred DC, O'Connell P, Fuqua SA, Osborne CK.

Breast Cancer Res Treat. 1994;32(1):13-8. Review.

PMID:
7819582
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk